Research Article
Standardised Neuropsychological Assessment for the Selection of Patients Undergoing DBS for Parkinson’s Disease
Table 3
Patient medication characteristics before and after DBS.
| | STN () | GPi () | Before DBS | After DBS | | Before DBS | After DBS | |
| Levodopa-equivalent dosage (mg/d) | 1321.82 ± 638.68 | 863.73 ± 583.92 | 0.00 | 1263.40 ± 971.08 | 1205.10 ± 626.68 | 0.81 | Dopamine agonist treatment (, %) | 15, 46.9% | 6, 18.8% | 0.01 | 7, 21.9% | 5, 15.6% | 0.16 |
|
|